Marshall Wace, LLP Ars Pharmaceuticals, Inc. Comm Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Marshall Wace, LLP holds 77,879 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,879
Holding current value
$0
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
77,879 New
77,879 $0
Q2 2023

Aug 14, 2023
BUY
N/A
35,193 Added 89.26%
74,621 $0
Q1 2023

May 15, 2023
BUY
N/A
7,417 Added 23.17%
39,428 $0
Q4 2022

Feb 14, 2023
BUY
N/A
32,011 New
32,011 $0
Q4 2021

Feb 14, 2022
SELL
N/A
-275,567 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
275,567 New
275,567 $2.75 Million

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email